Healing Beyond Relief

Go beyond simply managing symptoms! Offer your patients better healing with PROKERA the ONLY amniotic membrane device...

  • Demonstrated sustained reduction of DEWS score from 3.25 to 1.44 with one treatment in 3-5 days.
  • Recognized by the FDA to reduce inflammation, minimize corneal scarring and inhibiting angiogenesis.
  • Over 20 years of proven clinical performance

Learn more about Cryopreserved Amniotic Membrane and its outcome successes.

Sign-up to our new Amniotic Membrane Success Series. 

testimonials.png

“For many years, I suffered in pain from my dry eyes which eventually led to a corneal ulcer. My eyes were constantly itchy and red and my vision fluctuated. The treatment with PROKERA was quick and simple, and felt similar to a contact lens being inserted. My vision has improved, which is crucial to me as an artist. PROKERA has truly changed my quality of life and brought me back to feeling normal again."

FACTS: Demonstrated sustained reduction of DEWS score from 3.25 to 1.44 with one treatment in 3-5 days.

The DRy Eye Amniotic Membrane (DREAM) study evaluate the efficacy of cryopreserved amniotic membrane (CAM) in reducing
signs and symptoms of dry eye disease (DED) in a large patient population. Learn more on how PROKERA self-retained CAM accelerated the recovery of corneal surface health in patients with moderate and severe DED.

 

Download the Latest in Dry Eye Treatments DREAM Study link

 

Bio-Tissue in the Press

OO-Stacked-logo.png
Citizen Tribune.jpg
EyeWorld.png
Global Newswire.png
Ocular-Surgery-News-500x200.jpg
omd_logo_sm.jpg